We provide a test that generates objective insights into whether a patient has above-normal levels of the MAF gene.
In doing so, we enable pathologists with a new tool for oncologists expanding their possibilities to treat patients effectively and efficiently with bisphosphonates while minimising the possible risk of a relapse in the future.
Our dedication and drive to generate clinical results, offers a new proven perspective that will progress precision medicine today.
Industry
Biotechnology Research, Specialty (except Psychiatric and Substance Abuse) Hospitals, Health Care and Social Assistance
HQ Location
Calle de París, 175
4-2
Barcelona, Cataluña 08036, ES
Keywords
Precision medicinebreast cancerand cancer diagnosticsdiagnostic assaydiagnostic solutionclinical cancercompanion diagnostic solutionbone oncologytreatment strategies